EC
EntryPoint Capital Portfolio holdings
AUM
$200M
1-Year Return
6.93%
This Quarter Return
-2.53%
1 Year Return
+6.93%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$68.4M
AUM Growth
-$43.1M
(-39%)
Cap. Flow
-$41.9M
Cap. Flow
% of AUM
-61.24%
Top 10 Holdings %
Top 10 Hldgs %
2.86%
Holding
1,768
New
383
Increased
275
Reduced
163
Closed
947
Top Buys
| 1 |
Global Ship Lease
GSL
|
+$200K |
| 2 |
Delek US
DK
|
+$197K |
| 3 |
CoStar Group
CSGP
|
+$197K |
| 4 |
Skechers
SKX
|
+$196K |
| 5 |
XIFR
XPLR Infrastructure, LP
XIFR
|
+$196K |
Top Sells
| 1 |
GXO Logistics
GXO
|
+$470K |
| 2 |
Unisys
UIS
|
+$454K |
| 3 |
Schrodinger
SDGR
|
+$428K |
| 4 |
Leggett & Platt
LEG
|
+$408K |
| 5 |
Sutro Biopharma
STRO
|
+$394K |
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Industrials | 14.9% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Healthcare | 13.87% |
| 5 | Technology | 13.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Nutanix
NTNX
$20.3B
| $90.8K | 0.13% |
1,598
+1,294
| +426% | +$73.6K |
|
352
Helen of Troy
HELE
$563M
| $90.7K | 0.13% |
978
-2,059
| -68% | -$191K |
|
353
Atkore
ATKR
$1.97B
| $90.5K | 0.13% |
+671
| New | +$90.5K |
|
354
Credo Technology Group
CRDO
$25.8B
| $90.2K | 0.13% |
2,823
+2,056
| +268% | +$65.7K |
|
355
Zebra Technologies
ZBRA
$16B
| $89.9K | 0.13% |
+291
| New | +$89.9K |
|
356
Live Oak Bancshares
LOB
$1.74B
| $89.8K | 0.13% |
+2,561
| New | +$89.8K |
|
357
Vistra
VST
$65.7B
| $89.7K | 0.13% |
+1,043
| New | +$89.7K |
|
358
Southern Copper
SCCO
$84B
| $89.5K | 0.13% |
+864
| New | +$89.5K |
|
359
Adobe
ADBE
$150B
| $89.4K | 0.13% |
161
-285
| -64% | -$158K |
|
|
MORF
360
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $89.4K | 0.13% |
+2,625
| New | +$89.4K |
|
361
ServisFirst Bancshares
SFBS
$4.72B
| $88.4K | 0.13% |
1,399
+1,398
| +139,800% | +$88.3K |
|
362
Nature's Sunshine
NATR
$302M
| $88.3K | 0.13% |
+5,858
| New | +$88.3K |
|
363
Peoples Bancorp
PEBO
$1.11B
| $88K | 0.13% |
2,934
-1,417
| -33% | -$42.5K |
|
364
Phathom Pharmaceuticals
PHAT
$882M
| $87.6K | 0.13% |
8,503
-10,877
| -56% | -$112K |
|
365
Dyne Therapeutics
DYN
$1.89B
| $87.5K | 0.13% |
2,479
-5,073
| -67% | -$179K |
|
366
Nice
NICE
$8.83B
| $87.4K | 0.13% |
508
+443
| +682% | +$76.2K |
|
367
Simulations Plus
SLP
$285M
| $87.2K | 0.13% |
1,794
+401
| +29% | +$19.5K |
|
368
Corning
GLW
$62B
| $87.2K | 0.13% |
2,245
-3,273
| -59% | -$127K |
|
|
ENV
369
DELISTED
ENVESTNET, INC.
ENV
| $86.9K | 0.13% |
+1,389
| New | +$86.9K |
|
|
ITCI
370
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $86.8K | 0.13% |
1,268
-899
| -41% | -$61.6K |
|
371
Sierra Bancorp
BSRR
$413M
| $86.3K | 0.13% |
+3,858
| New | +$86.3K |
|
372
Collegium Pharmaceutical
COLL
$1.19B
| $86.1K | 0.13% |
2,675
+435
| +19% | +$14K |
|
373
APA Corp
APA
$7.75B
| $85.8K | 0.13% |
+2,916
| New | +$85.8K |
|
374
Uber
UBER
$199B
| $85.8K | 0.13% |
1,180
-1,243
| -51% | -$90.3K |
|
375
Olin
OLN
$2.87B
| $85K | 0.12% |
+1,802
| New | +$85K |
|